Multiple Myeloma Clinical Trial

Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients

Summary

An observational study in evaluating the clinical impact of procalcitonin on the care of Stem cell transplant recipient and its performance as an adjunct in the diagnosis and prognostication of Infectious processes

View Full Description

Full Description

The overall goal of this project will be to provide new insights into the use of biomarkers in surveillance for infectious processes in Stem Cell Transplant recipients by evaluating the added impact of procalcitonin testing on detection of infectious processes

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients age 18-95 years with Multiple Myeloma (MM) undergoing stem cell transplantation

Exclusion Criteria:

None

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

100

Study ID:

NCT02035189

Recruitment Status:

Completed

Sponsor:

University of Arkansas

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Arkansas for Medical Sciences
Little rock Arkansas, 72205, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

100

Study ID:

NCT02035189

Recruitment Status:

Completed

Sponsor:


University of Arkansas

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider